摘要
背景:极化气道上皮细胞培养模拟囊性纤维化跨膜传导调节(CFTR)缺陷是CF和生物医学研究的关键。RNA干扰已经证明了它在产生各种病症击倒模型的价值。最近,利用CRISPR-Cas9的基因组编辑,人工内切酶编辑是基因失活的工具箱中的一个有价值的补充。方法:Calu-3细胞和原代细胞被编码有小发夹RNA(shRNA)序列的HIV-1来源的慢病毒载体(LVV)或靶向CFTR的CRISPR-Cas9组件与GFP转换。GFP阳性细胞分选后,通过RT-qPCR和Western blot测定极化或分化细胞的方法来测量CFTR基因表达。Ussing灌流室评估了CFTR通道功能。II-8的分泌,细胞的增殖和迁移也在转导细胞中有所研究。结果:shRNA干扰和CRISPRCas9策略有效地降低了在Calu-3细胞中CFTR基因的表达。强CFTR击倒模式在CRISPR-Cas9-修饰细胞功能水平中得到证实。CFTR基因特异性shRNA序列没有减少原发性细胞基因的表达,而CRISPR-Cas9-mediated基因修饰的活性与降低上皮分泌及应对CFTR抑制剂相关。CFTR在CRISPR-Cas9-modified Calu-3细胞的失活不影响迁移和增殖,但略有增加基础分泌白细胞介素-8。结论:我们产生的CFTRinactivated细胞系和显示在一个单一的LVV CRISPR-Cas9矢量化有效地促进CFTR原细胞失活。这些结果对工程师CF上皮细胞的基因控制提供了一个新的协议,这些研究在CFTR表达控制方面铺平了道路。
关键词: CFTR,CRISPR-Cas9,囊性纤维化,慢病毒载体,原发性细胞,RNA干扰。
Current Gene Therapy
Title:CFTR Inactivation by Lentiviral Vector-mediated RNA Interference and CRISPR-Cas9 Genome Editing in Human Airway Epithelial Cells
Volume: 15 Issue: 5
Author(s): Jessica Bellec, Marc Bacchetta, Davide Losa, Ignacio Anegon, Marc Chanson and Tuan Huy Nguyen
Affiliation:
关键词: CFTR,CRISPR-Cas9,囊性纤维化,慢病毒载体,原发性细胞,RNA干扰。
摘要: Background: Polarized airway epithelial cell cultures modelling Cystic Fibrosis Transmembrane conductance Regulator (CFTR) defect are crucial for CF and biomedical research. RNA interference has proven its value to generate knockdown models for various pathologies. More recently, genome editing using CRISPR-Cas9 artificial endonuclease was a valuable addition to the toolbox of gene inactivation. Methods: Calu-3 cells and primary HAECs were transduced with HIV-1-derived lentiviral vectors (LVV) encoding small hairpin RNA (shRNA) sequence or CRISPR-Cas9 components targeting CFTR alongside GFP. After sorting of GFP-positive cells, CFTR expression was measured by RT-qPCR and Western blot in polarized or differentiated cells. CFTR channel function was assessed in Ussing chambers. Il-8 secretion, proliferation and cell migration were also studied in transduced cells. Results: shRNA interference and CRISPRCas9 strategies efficiently decreased CFTR expression in Calu-3 cells. Strong CFTR knockdown was confirmed at the functional level in CRISPR-Cas9-modified cells. CFTR-specific shRNA sequences did not reduce gene expression in primary HAECs, whereas CRISPR-Cas9-mediated gene modification activity was correlated with a reduction of transepithelial secretion and response to a CFTR inhibitor. CFTR inactivation in the CRISPR-Cas9-modified Calu-3 cells did not affect migration and proliferation but slightly increased basal interleukin-8 secretion. Conclusion: We generated CFTRinactivated cell lines and demonstrated that CRISPR-Cas9 vectorised in a single LVV efficiently promotes CFTR inactivation in primary HAECs. These results provide a new protocol to engineer CF primary epithelia with their isogenic controls and pave the way for manipulation of CFTR expression in these cultures.
Export Options
About this article
Cite this article as:
Bellec Jessica, Bacchetta Marc, Losa Davide, Anegon Ignacio, Chanson Marc and Nguyen Tuan Huy, CFTR Inactivation by Lentiviral Vector-mediated RNA Interference and CRISPR-Cas9 Genome Editing in Human Airway Epithelial Cells, Current Gene Therapy 2015; 15 (5) . https://dx.doi.org/10.2174/1566523215666150812115939
DOI https://dx.doi.org/10.2174/1566523215666150812115939 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Melatonin Signaling in Health and Disease
Melatonin regulates a multitude of physiological functions, including circadian rhythms, acting as a scavenger of free radicals, an anti-inflammatory agent, a modulator of mitochondrial homeostasis, an antioxidant, and an enhancer of nitric oxide bioavailability. AANAT is the rate-limiting enzyme responsible for converting serotonin to NAS, which is further converted to ...read more
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers.
Programmed cell death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
The now and future of gene transfer technologies
Gene and cell therapies rely on a gene delivery system which is safe and effective. Both viral and non-viral vector systems are available with specific pros and cons. The choice of a vector system is largely dependent on the application which is a balance between target tissue/disease and safety, efficacy ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
GEFT, A Rho Family Guanine Nucleotide Exchange Factor, Regulates Lens Differentiation through a Rac1-Mediated Mechanism
Current Molecular Medicine Expectancy and the Treatment of Depression: A Review of Experimental Methodology and Effects on Patient Outcome
Current Psychiatry Reviews Biological and Pharmacological Activities of 1,3,4-Thiadiazole Based Compounds
Mini-Reviews in Medicinal Chemistry Role of Chitosan Biomaterials in Drug Delivery Systems: A Patent Perspective
Recent Patents on Materials Science DNA Minor Groove Binders: an Overview on Molecular Modeling and QSAR Approaches
Current Medicinal Chemistry Function and Regulation of Tumor Necrosis Factor Receptor Type 2
Current Medicinal Chemistry Buccoadhesive Dosage Form Containing Antifungal Agent for Treating Oropharyngeal Candidiasis: A Review
Current Drug Therapy Recent Developments and Applications of Derivative Spectrophotometry in Pharmaceutical Analysis
Current Pharmaceutical Analysis Stem Cell Therapies for the Lysosomal Storage Diseases – the Quintessential Neurodegenerative Diseases
Current Stem Cell Research & Therapy GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders Personalized Medicine in a Consumer Age
Current Pharmacogenomics and Personalized Medicine Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses
Current Pharmaceutical Biotechnology Progress in Structure-Based Design of EGFR Inhibitors
Current Drug Targets Molecular Mechanisms, Proteinopathies and Therapeutic Strategies in Neurodegenerative Disorders
Current Genomics Inorganic Nanoparticles for In Vitro Cancer Diagnosis: A Patent Review
Recent Patents on Nanomedicine Arginine-Glycine-Aspartic Acid-anchored Curcumin-based Nanotherapeutics Inhibit Pyroptosis-induced Cytokine Release Syndrome for <i>In Vivo</i> and <i>In Vitro</i> Sepsis Applications
Current Pharmaceutical Design Current Status of Newer Antiinfectives
Recent Patents on Anti-Infective Drug Discovery Opportunities and Challenges for Niosomes as Drug Delivery Systems
Current Drug Delivery Anti-VEGF Treatment of Anterior Segment Disorders of the Eye
Current Drug Therapy New Perspectives on Acetaminophen
Current Cardiology Reviews